Search

Showing "11154" results for ""

Atazanavir: positive opinion in EU, but only for treatment-experienced and only when boosted

'Weight of evidence' suggests that HAART increases the risk of heart disease, says NEJM editorial

US and UK announce `Joint Special Task Force` on HIV/AIDS

Short course AZT prevented MTCT of HIV only for women with low viral load

Pulse therapy may be an option for a minority on HAART

Warning on Kaletra, tenofovir and ddI interaction after case of multiple severe toxicities

HIV prevalence increases by 20% in UK in one year

Palliative care and home-based care for HIV

UNAIDS: Injecting drug use fuelling exploding HIV epidemics

UNAIDS: Gay men still the group most affected by HIV in many rich countries

UNAIDS: HIV prevalence increases 10% in South America and Caribbean

UNAIDS says one in five adults now HIV-positive in southern Africa

UNAIDS: HIV prevalence surges to 1.5m in Eastern Europe and Central Asia

Growing political momentum behind war on AIDS

HAART can be safely delayed until CD4 cell count falls to 200, provided individuals are adherent

Tipranavir now available for emergency use in UK

Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment

African-Americans, Latinos and gay men bear the brunt of new US HIV infections

Receive the latest HIV research and conference news

Showing "11154" results for ""

Atazanavir: positive opinion in EU, but only for treatment-experienced and only when boosted

'Weight of evidence' suggests that HAART increases the risk of heart disease, says NEJM editorial

US and UK announce `Joint Special Task Force` on HIV/AIDS

Short course AZT prevented MTCT of HIV only for women with low viral load

Pulse therapy may be an option for a minority on HAART

Warning on Kaletra, tenofovir and ddI interaction after case of multiple severe toxicities

HIV prevalence increases by 20% in UK in one year

Palliative care and home-based care for HIV

UNAIDS: Injecting drug use fuelling exploding HIV epidemics

UNAIDS: Gay men still the group most affected by HIV in many rich countries

UNAIDS: HIV prevalence increases 10% in South America and Caribbean

UNAIDS says one in five adults now HIV-positive in southern Africa

UNAIDS: HIV prevalence surges to 1.5m in Eastern Europe and Central Asia

Growing political momentum behind war on AIDS

HAART can be safely delayed until CD4 cell count falls to 200, provided individuals are adherent

Tipranavir now available for emergency use in UK

Gastrointestinal side-effects lead one in eight to change HAART regimen in first year of treatment

African-Americans, Latinos and gay men bear the brunt of new US HIV infections

Receive the latest HIV research and conference news